(19)
(11) EP 4 580 754 A1

(12)

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23764617.9

(22) Date of filing: 31.08.2023
(51) International Patent Classification (IPC): 
A61P 35/00(2006.01)
A61K 47/68(2017.01)
C07K 16/28(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07K 16/2842; A61K 2039/505; C07K 2317/24; C07K 2317/73; C07K 2317/77; C07K 2317/92; C07K 2317/94; A61K 47/6903; A61K 47/6849; A61K 47/6889
(86) International application number:
PCT/EP2023/073919
(87) International publication number:
WO 2024/047172 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 31.08.2022 EP 22193257

(71) Applicant: Targinta AB
22381 Lund (SE)

(72) Inventors:
  • LUNDGREN ÅKERLUND, Evy
    237 33 Bjärred (SE)
  • CHMIELARSKA MASOUMI, Katarzyna
    224 67 Lund (SE)
  • HUANG, Xiaoli
    245 64 Hjärup (SE)

(74) Representative: Høiberg P/S 
Adelgade 12
1304 Copenhagen K
1304 Copenhagen K (DK)

   


(54) AN INTEGRIN ALPHA10 ANTIBODY DRUG CONJUGATE